Cargando…
The Implications of Metabotypes for Rationalizing Therapeutics in Infants and Children
Autores principales: | Katsila, Theodora, Patrinos, George P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518156/ https://www.ncbi.nlm.nih.gov/pubmed/26284229 http://dx.doi.org/10.3389/fped.2015.00068 |
Ejemplares similares
-
Whole genome sequencing in pharmacogenomics
por: Katsila, Theodora, et al.
Publicado: (2015) -
Nutrigenomics: A controversy
por: Pavlidis, Cristiana, et al.
Publicado: (2015) -
Pharmacometabolomics Informs Viromics toward Precision Medicine
por: Balasopoulou, Angeliki, et al.
Publicado: (2016) -
Searching for Clinically Relevant Biomarkers in Geriatric Oncology
por: Katsila, Theodora, et al.
Publicado: (2018) -
Urinary metabotypes of newborns with perinatal asphyxia undergoing therapeutic hypothermia
por: Valerio, Enrico, et al.
Publicado: (2022)